{"title": "Johnson & Johnson inicia el ensayo cl\u00ednico en Fase 3 del candidato de vacuna para la COVID-19 de Janssen", "author": null, "url": "https://www.prnewswire.com/news-releases/johnson-amp-johnson-inicia-el-ensayo-clinico-en-fase-3-del-candidato-de-vacuna-para-la-covid-19-de-janssen-854359037.html", "hostname": "prnewswire.com", "description": "/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (la compa\u00f1\u00eda) anunci\u00f3 hoy el lanzamiento de su ensayo pivote en Fase 3 a gran escala para m\u00faltiples pa\u00edses...", "sitename": "PR Newswire", "date": "2020-09-23", "id": null, "license": null, "body": null, "comments": "Share this article", "commentsbody": null, "raw_text": null, "text": "Johnson & Johnson inicia el ensayo cl\u00ednico en Fase 3 del candidato de vacuna para la COVID-19 de Janssen\n[Johnson & Johnson](/news/johnson-%26-johnson/)\n23 Sep, 2020, 07:55 ET\n[]\n- Johnson & Johnson inicia el ensayo cl\u00ednico pivote mundial en Fase 3 del candidato de vacuna para la COVID-19 de Janssen\nLos primeros participantes reciben la dosis del ensayo en Fase 3 (ENSEMBLE) que eval\u00faa la eficacia y seguridad del candidato de vacuna de la COVID-19 de Janssen, JNJ-78436735, conocido tambi\u00e9n como Ad26.COV2.S\nNEW BRUNSWICK, Nueva Jersey, 23 de septiembre de 2020 /PRNewswire/ -- Johnson & Johnson (NYSE:\n[JNJ](#financial-modal)) (la compa\u00f1\u00eda) anunci\u00f3 hoy el lanzamiento de su ensayo pivote en Fase 3 a gran escala para m\u00faltiples pa\u00edses (ENSEMBLE) para su candidato de vacuna contra la COVID-19, JNJ-78436735, que est\u00e1 siendo desarrollado por Janssen Pharmaceutical Companies. El inicio del ensayo ENSEMBLE sigue los resultados interinos positivos del ensayo cl\u00ednico en Fase 1/2a de la compa\u00f1\u00eda, que ha demostrado un perfil de seguridad e inmunogenecidad tras una vacuna \u00fanica como apoyo al resultado superior. Estos resultados se han enviado a medRxiv, y se van a publicar de forma online inminentemente. Bas\u00e1ndose en estos resultados y tras debates con la U.S. Food and Drug Administration (FDA), ENSEMBLE va a reclutar hasta 60.000 voluntarios en tres continentes, y estudiar\u00e1 la seguridad y eficacia de una vacuna de una sola dosis frente al placebo para prevenir la COVID-19.\nJohnson & Johnson ha continuado con el crecimiento de su capacidad de fabricaci\u00f3n, y sigue la pista para cumplir con su objetivo de proporcionar 1.000 millones de dosis de vacunas cada a\u00f1o. La compa\u00f1\u00eda se ha comprometido a proporcionar una vacuna de coste contenido sin \u00e1nimo de lucro para uso en emergencias pand\u00e9micas, y prev\u00e9 que los primeros lotes de una vacuna de la COVID-19 est\u00e9n disponibles para autorizaci\u00f3n como uso de emergencia a principios del a\u00f1o 2021, si demuestra ser segura y eficaz.\nJohnson & Johnson va a desarrollar y probar su candidato de vacuna de la COVID-19 seg\u00fan los elevados est\u00e1ndares \u00e9ticos y los principios cient\u00edficos destacados. La compa\u00f1\u00eda se ha comprometido con la transparencia e informaci\u00f3n compartida relacionada con el estudio en Fase 3 ENSEMBLE \u2013 incluyendo el\n[protocolo del estudio](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=4217873583&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1522581176%26u%3Dhttps%253A%252F%252Fwww.jnj.com%252Fcoronavirus%252Fcovid-19-phase-3-study-clinical-protocol%26a%3Dstudy%2Bprotocol&a=protocolo+del+estudio).\n\"Al tiempo que la COVID-19 sigue impactando en las vidas del d\u00eda a d\u00eda de las personas en todo el mundo, nuestro objetivo sigue siendo el mismo \u2013 mejorar el alcance mundial y la innovaci\u00f3n cient\u00edfica de nuestra compa\u00f1\u00eda para ayudar a finalizar con esta pandemia\", coment\u00f3 Alex Gorsky, presidente y consejero delegado de Johnson & Johnson. \"Como principal compa\u00f1\u00eda de cuidado de la salud del mundo, vamos a llevar nuestras mejores mentes cient\u00edficas y los est\u00e1ndares de seguridad m\u00e1s rigurosos, en colaboraci\u00f3n con los regladores, para acelerar la lucha contra esta pandemia. Este hito central demuestra nuestro esfuerzo continuado hacia la vacuna de la COVID-19 que se ha creado en colaboraci\u00f3n y compromiso profundo en un proceso cient\u00edfico considerable. Estamos comprometidos con la transparencia de los ensayos cl\u00ednicos y en compartir informaci\u00f3n relacionada con nuestro estudio, incluyendo detalles del protocolo de estudio\".\n\"Seguimos estando muy centrados en el desarrollo de la vacuna contra la COVID-19 que se necesita de forma urgente, segura y eficaz para los habitantes de todo el mundo\", indic\u00f3 Paul Stoffels, doctor, vicepresidente del Comit\u00e9 Ejecutivo y responsable cient\u00edfico de Johnson & Johnson. \"Valoramos de forma importante el apoyo y la colaboraci\u00f3n de nuestros socios cient\u00edficos y de las autoridades de salud mundiales al tiempo que nuestro equipo de expertos trabaja de forma desinteresada en el desarrollo de la vacuna y crecimiento de nuestra capacidad de producci\u00f3n con el fin de desplegar la vacuna para una autorizaci\u00f3n de uso de emergencia a principios de 2021\".\nEl candidato de vacuna de la COVID-19 de Janssen se aventaja de la plataforma de\n[tecnolog\u00eda AdVac\u00ae](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=2587155939&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1181941441%26u%3Dhttps%253A%252F%252Fwww.janssen.com%252Finfectious-diseases-and-vaccines%252Fpatented-technologies%26a%3DAdVac%25C2%25AE%2Btechnology&a=tecnolog%C3%ADa+AdVac%C2%AE) de la compa\u00f1\u00eda, que se ha utilizado para desarrollar y fabricar la vacuna contra el Ebola de Janssen aprobada por la Comisi\u00f3n Europea y para construir sus candidatos de vacuna contra Zika, RSV y VIH. La plataforma de tecnolog\u00eda AdVac\u00ae de Janssen se ha utilizado para vacunar a m\u00e1s de 100.000 personas hasta la fecha en programas de vacuna investigacionales de Janssen.\nLa tecnolog\u00eda AdVac\u00ae de Janssen, la vacuna, si consigue el \u00e9xito, se estima podr\u00eda lanzarse para seguir siendo estable durante dos a\u00f1os a una temperatura de -20 \u00b0C y al menos tres meses a 2-8\u00b0 C. Esto hace que el candidato de vacuna sea compatible con los canales de distribuci\u00f3n de vacuna est\u00e1ndares, sin necesitar de una nueva infraestructura que entre all\u00ed donde lo necesitan las personas.\nESTUDIO EN FASE 3 ENSEMBLE\nEl ensayo en Fase 3 ENSEMBLE es un ensayo cl\u00ednico aleatorio, doble ciego y controlado por placebo dise\u00f1ado para evaluar la seguridad y eficacia de una dosis de vacuna \u00fanica frente al placebo en hasta 60.000 adultos mayores de 18 a\u00f1os, incluyendo la representaci\u00f3n importante de los que tienen m\u00e1s de 60 a\u00f1os. El ensayo incluir\u00e1 los que padecen comorbidades asociadas a un amento del riesgo de la progresi\u00f3n de la COVID-19 severa y tambi\u00e9n las personas que no la padecen, y buscar\u00e1 reclutar a participantes en Argentina, Brasil, Chile, Colombia, M\u00e9xico, Per\u00fa, Sud\u00e1frica y Estados Unidos. Con el fin de evaluar la eficacia de la vacuna de la COVID-19 por medio de Janssen, se van a activar los pa\u00edses y ensayos cl\u00ednicos que padecen una incidencia elevada de la COVID-19 y la capacidad para conseguir un inicio r\u00e1pido.\nBas\u00e1ndose en el legado de acciones con un objetivo y en un compromiso para con la diversidad y la inclusi\u00f3n, la compa\u00f1\u00eda busca conseguir la representaci\u00f3n de las poblaciones que se han visto impactadas de forma desproporcionada por la pandemia por la implementaci\u00f3n del programa del ensayo en Fase 3 de la COVID-19. En Estados Unidos, estas incluyen la representaci\u00f3n destacada de participantes negros, hispanos/latinos, indios americanos y nativos de Alaska.\nENSEMBLE se est\u00e1 poniendo en marcha en colaboraci\u00f3n con la Biomedical Advanced Research and Development Authority (BARDA), parte de la Office of the Assistant Secretary for Preparedness and Response del U.S. Department of Health and Human Services (HHS) bajo el acuerdo de transacci\u00f3n HHSO100201700018C, adem\u00e1s del National Institute of Allergy and Infectious Diseases (NIAID), parte de los National Institutes of Health (NIH) del HHS.\nDe forma paralela, la compa\u00f1\u00eda tiene un principio de acuerdo para\n[colaborar](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=1577797497&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D125471153%26u%3Dhttps%253A%252F%252Fwww.jnj.com%252Four-company%252Fjohnson-johnson-announces-collaboration-in-principle-with-the-united-kingdom-on-additional-phase-3-study-and-agreement-to-supply-its-covid-19-vaccine-candidate%26a%3Dcollaborate&a=colaborar) con el Reino Unido de Gran Breta\u00f1a e Irlanda del Norte (Gobierno de Reino Unido) en un ensayo cl\u00ednico separado en Fase 3 en m\u00faltiples pa\u00edses para explorar el r\u00e9gimen de dos dosis del candidato de vacuna de Janssen.\n\"Con nuestro candidato de vacuna dentro de los ensayos mundiales en fase 3, estamos un paso m\u00e1s cerca para descubrir una soluci\u00f3n para la COVID-19. Hemos utilizado una aproximaci\u00f3n cient\u00edfica elevada y basada en las pruebas para seleccionar este candidato de vacuna. Estamos muy agradecidos de los esfuerzos incansables de nuestros investigadores y de las contribuciones vitales de los participantes que han sido voluntarios para formar parte en estos estudios. Juntos, estamos luchando para vencer a esta pandemia\", declar\u00f3 Mathai Mammen, doctor, Ph.D. y responsable mundial de Janssen Research & Development, LLC, Johnson & Johnson.\nLa compa\u00f1\u00eda est\u00e1 en negociaciones con muchos accionistas, incluyendo gobiernos nacionales y organizaciones gubernamentales, como parte de sus esfuerzos para cumplir con su compromiso para hacer que el candidato de vacuna sea accesible en todo el mundo, proporcionando la vacuna que ha demostrado ser segura y tambi\u00e9n siguiendo las aprobaciones normativas.\nSi desea m\u00e1s informaci\u00f3n sobre la aproximaci\u00f3n m\u00faltiple prolongada de Johnson & Johnson para ayudar a luchar contra la pandemia, visite:\n[www.jnj.com/coronavirus](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=2174915427&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D972281942%26u%3Dhttp%253A%252F%252Fwww.jnj.com%252Fcoronavirus%26a%3Dwww.jnj.com%252Fcoronavirus&a=www.jnj.com%2Fcoronavirus).\nAcerca de Johnson & Johnson\nEn Johnson & Johnson, creemos que la buena salud es la base de vidas vibrantes, comunidades pr\u00f3speras y progreso hacia adelante. Es por eso que durante m\u00e1s de 130 a\u00f1os, hemos tenido como objetivo mantener a las personas bien en todas las edades y en todas las etapas de la vida. Hoy en d\u00eda, como la compa\u00f1\u00eda de atenci\u00f3n m\u00e9dica m\u00e1s grande y con mayor base del mundo, estamos comprometidos a utilizar nuestro alcance y tama\u00f1o para hacer el bien. Nos esforzamos por mejorar el acceso y la asequibilidad, crear comunidades m\u00e1s saludables y poner una mente, cuerpo y medio ambiente saludables al alcance de todos, en todas partes. Estamos mezclando nuestro coraz\u00f3n, nuestra ciencia y nuestro ingenio para cambiar profundamente la trayectoria de la salud para la humanidad. M\u00e1s informaci\u00f3n en\n[www.jnj.com](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=3848262118&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1797651163%26u%3Dhttp%253A%252F%252Fwww.jnj.com%252F%26a%3Dwww.jnj.com&a=www.jnj.com). S\u00edganos en [@JNJNews](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=4155470862&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D3430601698%26u%3Dhttp%253A%252F%252Fwww.twitter.com%252Fjnjnews%26a%3D%2540JNJNews&a=%40JNJNews).\nAcerca de Janssen Pharmaceutical Companies\nEn Janssen, estamos creando un futuro donde la enfermedad es cosa del pasado. Somos las Pharmaceutical Companies of Johnson & Johnson, trabajando incansablemente para hacer que ese futuro sea una realidad para los pacientes de todas partes, luchando contra la enfermedad con la ciencia, mejorando el acceso con ingenio y curando la desesperanza con el coraz\u00f3n. Nos centramos en \u00e1reas de medicina donde podemos marcar la mayor diferencia: Cardiovascular & Metabolismo, Inmunolog\u00eda, Enfermedades Infecciosas & Vacunas, Neurociencia, Oncolog\u00eda, e Hipertensi\u00f3n Pulmonar. M\u00e1s informaci\u00f3n en\n[www.janssen.com](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=3845457817&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D3956113430%26u%3Dhttp%253A%252F%252Fwww.janssen.com%252F%26a%3Dwww.janssen.com&a=www.janssen.com). S\u00edganos en [@JanssenGlobal](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=930301523&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1289483207%26u%3Dhttps%253A%252F%252Ftwitter.com%252FJanssenGlobal%26a%3D%2540JanssenGlobal&a=%40JanssenGlobal).\nAviso a los inversores en relaci\u00f3n a las declaraciones prospectivas\nEste comunicado de prensa contiene \"declaraciones prospectivas\" tal como se definen en la Ley de Reforma de Litigios de Valores Privados de 1995 en relaci\u00f3n con el desarrollo de posibles reg\u00edmenes preventivos y de tratamiento para la COVID-19. Se advierte al lector que no conf\u00ede en estas declaraciones prospectivas. Estas declaraciones se basan en las expectativas actuales de eventos futuros. Si los supuestos subyacentes resultan inexactos o conocidos o desconocidos o se materializan los riesgos o incertidumbres, los resultados reales podr\u00edan variar materialmente de las expectativas y proyecciones de Pharmaceuticals Inc., y/o Johnson & Johnson. Los riesgos e incertidumbres incluyen, entre otros: desaf\u00edos e incertidumbres inherentes a la investigaci\u00f3n y el desarrollo de productos, incluida la incertidumbre del \u00e9xito cl\u00ednico y de la obtenci\u00f3n de aprobaciones reglamentarias; incertidumbre de \u00e9xito comercial; dificultades y retrasos en la fabricaci\u00f3n; competencia, incluidos los avances tecnol\u00f3gicos, los nuevos productos y las patentes alcanzadas por los competidores; impugnaciones de las patentes; problemas de eficacia o seguridad del producto que dan lugar a retiradas de productos o medidas reglamentarias; cambios en el comportamiento y los patrones de gasto de los compradores de productos y servicios de atenci\u00f3n m\u00e9dica; cambios en las leyes y reglamentos aplicables, incluidas las reformas mundiales en materia de atenci\u00f3n de la salud; y tendencias hacia la contenci\u00f3n de costes de atenci\u00f3n m\u00e9dica. Puede encontrar otra lista y descripciones de estos riesgos, incertidumbres y otros factores en el Informe Anual de Johnson & Johnson en el Formulario 10-K para el a\u00f1o fiscal terminado el 29 de diciembre de 2019, incluyendo en las secciones subtituladas \"Nota de precauci\u00f3n con respecto a las declaraciones prospectivas\" y \"Punto 1A\". Factores de Riesgo,\" y en el Informe Trimestral de la compa\u00f1\u00eda m\u00e1s recientemente presentado en el Formulario 10-Q, y las presentaciones posteriores de la compa\u00f1\u00eda ante la Comisi\u00f3n de Valores y Bolsa. Copias de estas presentaciones est\u00e1n disponibles en l\u00ednea en\n[www.sec.gov](http://www.sec.gov), [www.jnj.com](http://www.jnj.com) o a petici\u00f3n de Johnson & Johnson. Ni Janssen Pharmaceutical Companies ni Johnson & Johnson se comprometen a actualizar ninguna declaraci\u00f3n prospectiva como resultado de nueva informaci\u00f3n o eventos o desarrollos futuros.\nLogo -\n[https://mma.prnewswire.com/media/403394/Johnson_and_Johnson_Logo.jpg](https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=175754704&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D650214627%26u%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F403394%252FJohnson_and_Johnson_Logo.jpg%26a%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F403394%252FJohnson_and_Johnson_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F403394%2FJohnson_and_Johnson_Logo.jpg)\nRelated Links\nSOURCE Johnson & Johnson", "language": null, "image": "https://mma.prnewswire.com/media/403394/Johnson_and_Johnson_Logo.jpg?p=facebook", "pagetype": "articles", "links": ["/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "https://portal.prnewswire.com/Login.aspx", "https://www.prnewswire.com/account/online-membership-form/", "https://gdpr.cision.com/", "https://portal.prnewswire.com/Login.aspx", "/", "/news-releases/", "/products/overview/", "/contact-us/", "#", "/news-releases/", "/news-releases/news-releases-list/", "/news-releases/all-public-company-news/", "/news-releases/english-releases/", "/news-releases/", "/news-releases/multimedia/", "/news-releases/multimedia/multimedia-list/", "/news-releases/photos/photos-list/", "/news-releases/videos/videos-list/", "/news-releases/multimedia/", "/news-releases/latest-news-topics/", "/news-releases/latest-news-topics/", "#", "/news-releases/automotive-transportation-latest-news/", "/news-releases/automotive-transportation-latest-news/automotive-transportation-latest-news-list/", "/news-releases/automotive-transportation-latest-news/aerospace-defense-list/", "/news-releases/automotive-transportation-latest-news/air-freight-list/", "/news-releases/automotive-transportation-latest-news/airlines-aviation-list/", "/news-releases/automotive-transportation-latest-news/automotive-list/", "/news-releases/automotive-transportation-latest-news/maritime-shipbuilding-list/", "/news-releases/automotive-transportation-latest-news/railroads-and-intermodal-transportation-list/", "/news-releases/automotive-transportation-latest-news/supply-chain-logistics-list/", "/news-releases/automotive-transportation-latest-news/transportation-trucking-railroad-list/", "/news-releases/automotive-transportation-latest-news/travel-list/", "/news-releases/automotive-transportation-latest-news/trucking-and-road-transportation-list/", "/news-releases/automotive-transportation-latest-news/", "/news-releases/automotive-transportation-latest-news/automotive-transportation-latest-news-list/", "/news-releases/business-technology-latest-news/", "/news-releases/business-technology-latest-news/business-technology-latest-news-list/", "/news-releases/business-technology-latest-news/blockchain-list/", "/news-releases/business-technology-latest-news/broadcast-tech-list/", "/news-releases/business-technology-latest-news/computer-electronics-list/", "/news-releases/business-technology-latest-news/computer-hardware-list/", "/news-releases/business-technology-latest-news/computer-software-list/", "/news-releases/business-technology-latest-news/data-analytics-list/", "/news-releases/business-technology-latest-news/electronic-commerce-list/", "/news-releases/business-technology-latest-news/electronic-components-list/", "/news-releases/business-technology-latest-news/electronic-design-automation-list/", "/news-releases/business-technology-latest-news/financial-technology-list/", "/news-releases/business-technology-latest-news/high-tech-security-list/", "/news-releases/business-technology-latest-news/internet-technology-list/", "/news-releases/business-technology-latest-news/nanotechnology-list/", "/news-releases/business-technology-latest-news/networks-list/", "/news-releases/business-technology-latest-news/peripherals-list/", "/news-releases/business-technology-latest-news/semiconductors-list/", "/news-releases/business-technology-latest-news/", "/news-releases/business-technology-latest-news/business-technology-latest-news-list/", "/news-releases/entertainment-media-latest-news/", "/news-releases/entertainment-media-latest-news/entertainment-media-latest-news-list/", "/news-releases/entertainment-media-latest-news/advertising-list/", "/news-releases/entertainment-media-latest-news/art-list/", "/news-releases/entertainment-media-latest-news/books-list/", "/news-releases/entertainment-media-latest-news/entertainment-list/", "/news-releases/entertainment-media-latest-news/film-and-motion-picture-list/", "/news-releases/entertainment-media-latest-news/magazines-list/", "/news-releases/entertainment-media-latest-news/music-list/", "/news-releases/entertainment-media-latest-news/publishing-information-services-list/", "/news-releases/entertainment-media-latest-news/radio-list/", "/news-releases/entertainment-media-latest-news/television-list/", "/news-releases/entertainment-media-latest-news/", "/news-releases/entertainment-media-latest-news/entertainment-media-latest-news-list/", "/news-releases/financial-services-latest-news/", "/news-releases/financial-services-latest-news/financial-services-latest-news-list/", "/news-releases/financial-services-latest-news/accounting-news-issues-list/", "/news-releases/financial-services-latest-news/acquisitions-mergers-and-takeovers-list/", "/news-releases/financial-services-latest-news/banking-financial-services-list/", "/news-releases/financial-services-latest-news/bankruptcy-list/", "/news-releases/financial-services-latest-news/bond-stock-ratings-list/", "/news-releases/financial-services-latest-news/conference-call-announcements-list/", "/news-releases/financial-services-latest-news/contracts-list/", "/news-releases/financial-services-latest-news/cryptocurrency-list/", "/news-releases/financial-services-latest-news/dividends-list/", "/news-releases/financial-services-latest-news/earnings-list/", "/news-releases/financial-services-latest-news/earnings-forecasts-projections-list/", "/news-releases/financial-services-latest-news/financing-agreements-list/", "/news-releases/financial-services-latest-news/insurance-list/", "/news-releases/financial-services-latest-news/investment-opinions-list/", "/news-releases/financial-services-latest-news/joint-ventures-list/", "/news-releases/financial-services-latest-news/mutual-funds-list/", "/news-releases/financial-services-latest-news/private-placement-list/", "/news-releases/financial-services-latest-news/real-estate-list/", "/news-releases/financial-services-latest-news/restructuring-recapitalization-list/", "/news-releases/financial-services-latest-news/sales-reports-list/", "/news-releases/financial-services-latest-news/shareholder-activism-list/", "/news-releases/financial-services-latest-news/shareholder-meetings-list/", "/news-releases/financial-services-latest-news/stock-offering-list/", "/news-releases/financial-services-latest-news/stock-split-list/", "/news-releases/financial-services-latest-news/venture-capital-list/", "/news-releases/financial-services-latest-news/", "/news-releases/financial-services-latest-news/financial-services-latest-news-list/", "/news-releases/general-business-latest-news/", "/news-releases/general-business-latest-news/general-business-latest-news-list/", "/news-releases/general-business-latest-news/awards-list/", "/news-releases/general-business-latest-news/commercial-real-estate-list/", "/news-releases/general-business-latest-news/corporate-expansion-list/", "/news-releases/general-business-latest-news/earnings-list/", "/news-releases/general-business-latest-news/environmental-social-governance-list/", "/news-releases/general-business-latest-news/human-resource-workforce-management-list/", "/news-releases/general-business-latest-news/licensing-list/", "/news-releases/general-business-latest-news/new-products-services-list/", "/news-releases/general-business-latest-news/obituaries-list/", "/news-releases/general-business-latest-news/outsourcing-businesses-list/", "/news-releases/general-business-latest-news/overseas-real-estate-list/", "/news-releases/general-business-latest-news/personnel-announcements-list/", "/news-releases/general-business-latest-news/real-estate-transactions-list/", "/news-releases/general-business-latest-news/residential-real-estate-list/", "/news-releases/general-business-latest-news/small-business-services-list/", "/news-releases/general-business-latest-news/socially-responsible-investing-list/", "/news-releases/general-business-latest-news/surveys-polls-and-research-list/", "/news-releases/general-business-latest-news/trade-show-news-list/", "/news-releases/general-business-latest-news/", "/news-releases/general-business-latest-news/general-business-latest-news-list/", "#", "/news-releases/consumer-technology-latest-news/", "/news-releases/consumer-technology-latest-news/consumer-technology-latest-news-list/", "/news-releases/consumer-technology-latest-news/artificial-intelligence-list/", "/news-releases/consumer-technology-latest-news/blockchain-list/", "/news-releases/consumer-technology-latest-news/cloud-computing-internet-of-things-list/", "/news-releases/consumer-technology-latest-news/computer-electronics-list/", "/news-releases/consumer-technology-latest-news/computer-hardware-list/", "/news-releases/consumer-technology-latest-news/computer-software-list/", "/news-releases/consumer-technology-latest-news/consumer-electronics-list/", "/news-releases/consumer-technology-latest-news/cryptocurrency-list/", "/news-releases/consumer-technology-latest-news/data-analytics-list/", "/news-releases/consumer-technology-latest-news/electronic-commerce-list/", "/news-releases/consumer-technology-latest-news/electronic-gaming-list/", "/news-releases/consumer-technology-latest-news/financial-technology-list/", "/news-releases/consumer-technology-latest-news/mobile-entertainment-list/", "/news-releases/consumer-technology-latest-news/multimedia-internet-list/", "/news-releases/consumer-technology-latest-news/peripherals-list/", "/news-releases/consumer-technology-latest-news/social-media-list/", "/news-releases/consumer-technology-latest-news/science-tech-engineering-math-list/", "/news-releases/consumer-technology-latest-news/supply-chain-logistics-list/", "/news-releases/consumer-technology-latest-news/wireless-communications-list/", "/news-releases/consumer-technology-latest-news/", "/news-releases/consumer-technology-latest-news/consumer-technology-latest-news-list/", "/news-releases/energy-latest-news/", "/news-releases/energy-latest-news/energy-latest-news-list/", "/news-releases/energy-latest-news/alternative-energies-list/", "/news-releases/energy-latest-news/chemical-list/", "/news-releases/energy-latest-news/electrical-utilities-list/", "/news-releases/energy-latest-news/gas-list/", "/news-releases/energy-latest-news/general-manufacturing-list/", "/news-releases/energy-latest-news/mining-list/", "/news-releases/energy-latest-news/mining-metals-list/", "/news-releases/energy-latest-news/oil-energy-list/", "/news-releases/energy-latest-news/oil-and-gas-discoveries-list/", "/news-releases/energy-latest-news/utilities-list/", "/news-releases/energy-latest-news/water-utilities-list/", "/news-releases/energy-latest-news/", "/news-releases/energy-latest-news/energy-latest-news-list/", "/news-releases/environment-latest-news/", "/news-releases/environment-latest-news/environment-latest-news-list/", "/news-releases/environment-latest-news/conservation-recycling-list/", "/news-releases/environment-latest-news/environmental-issues-list/", "/news-releases/environment-latest-news/environmental-policy-list/", "/news-releases/environment-latest-news/environmental-products-services-list/", "/news-releases/environment-latest-news/green-technology-list/", "/news-releases/environment-latest-news/natural-disasters/", "/news-releases/environment-latest-news/", "/news-releases/environment-latest-news/environment-latest-news-list/", "/news-releases/heavy-industry-manufacturing-latest-news/", "/news-releases/heavy-industry-manufacturing-latest-news/heavy-industry-manufacturing-latest-news-list/", "/news-releases/heavy-industry-manufacturing-latest-news/aerospace-defense-list/", "/news-releases/heavy-industry-manufacturing-latest-news/agriculture-list/", "/news-releases/heavy-industry-manufacturing-latest-news/chemical-list/", "/news-releases/heavy-industry-manufacturing-latest-news/construction-building-list/", "/news-releases/heavy-industry-manufacturing-latest-news/general-manufacturing-list/", "/news-releases/heavy-industry-manufacturing-latest-news/hvac-list/", "/news-releases/heavy-industry-manufacturing-latest-news/machinery-list/", "/news-releases/heavy-industry-manufacturing-latest-news/machine-tools-metalworking-and-metallury-list/", "/news-releases/heavy-industry-manufacturing-latest-news/mining-list/", "/news-releases/heavy-industry-manufacturing-latest-news/mining-metals-list/", "/news-releases/heavy-industry-manufacturing-latest-news/paper-forest-products-containers-list/", "/news-releases/heavy-industry-manufacturing-latest-news/precious-metals-list/", "/news-releases/heavy-industry-manufacturing-latest-news/textiles-list/", "/news-releases/heavy-industry-manufacturing-latest-news/tobacco-list/", "/news-releases/heavy-industry-manufacturing-latest-news/", "/news-releases/heavy-industry-manufacturing-latest-news/heavy-industry-manufacturing-latest-news-list/", "/news-releases/telecommunications-latest-news/", "/news-releases/telecommunications-latest-news/telecommunications-latest-news-list/", "/news-releases/telecommunications-latest-news/carriers-and-services-list/", "/news-releases/telecommunications-latest-news/mobile-entertainment-list/", "/news-releases/telecommunications-latest-news/networks-list/", "/news-releases/telecommunications-latest-news/peripherals-list/", "/news-releases/telecommunications-latest-news/telecommunications-equipment-list/", "/news-releases/telecommunications-latest-news/telecommunications-industry-list/", "/news-releases/telecommunications-latest-news/voip-list/", "/news-releases/telecommunications-latest-news/wireless-communications-list/", "/news-releases/telecommunications-latest-news/", "/news-releases/telecommunications-latest-news/telecommunications-latest-news-list/", "#", "/news-releases/consumer-products-retail-latest-news/", "/news-releases/consumer-products-retail-latest-news/consumer-products-retail-latest-news-list/", "/news-releases/consumer-products-retail-latest-news/animals-pets-list/", "/news-releases/consumer-products-retail-latest-news/beers-wines-and-spirits-list/", "/news-releases/consumer-products-retail-latest-news/beverages-list/", "/news-releases/consumer-products-retail-latest-news/bridal-services-list/", "/news-releases/consumer-products-retail-latest-news/cannabis-list/", "/news-releases/consumer-products-retail-latest-news/cosmetics-and-personal-care-list/", "/news-releases/consumer-products-retail-latest-news/fashion-list/", "/news-releases/consumer-products-retail-latest-news/food-beverages-list/", "/news-releases/consumer-products-retail-latest-news/furniture-and-furnishings-list/", "/news-releases/consumer-products-retail-latest-news/home-improvements-list/", "/news-releases/consumer-products-retail-latest-news/household-consumer-cosmetics-list/", "/news-releases/consumer-products-retail-latest-news/household-products-list/", "/news-releases/consumer-products-retail-latest-news/jewelry-list/", "/news-releases/consumer-products-retail-latest-news/non-alcoholic-beverages-list/", "/news-releases/consumer-products-retail-latest-news/office-products-list/", "/news-releases/consumer-products-retail-latest-news/organic-food-list/", "/news-releases/consumer-products-retail-latest-news/product-recalls-list/", "/news-releases/consumer-products-retail-latest-news/restaurants-list/", "/news-releases/consumer-products-retail-latest-news/retail-list/", "/news-releases/consumer-products-retail-latest-news/supermarkets-list/", "/news-releases/consumer-products-retail-latest-news/toys-list/", "/news-releases/consumer-products-retail-latest-news/", "/news-releases/consumer-products-retail-latest-news/consumer-products-retail-latest-news-list/", "/news-releases/entertainment-media-latest-news/", "/news-releases/entertainment-media-latest-news/entertainment-media-latest-news-list/", "/news-releases/entertainment-media-latest-news/advertising-list/", "/news-releases/entertainment-media-latest-news/art-list/", "/news-releases/entertainment-media-latest-news/books-list/", "/news-releases/entertainment-media-latest-news/entertainment-list/", "/news-releases/entertainment-media-latest-news/film-and-motion-picture-list/", "/news-releases/entertainment-media-latest-news/magazines-list/", "/news-releases/entertainment-media-latest-news/music-list/", "/news-releases/entertainment-media-latest-news/publishing-information-services-list/", "/news-releases/entertainment-media-latest-news/radio-list/", "/news-releases/entertainment-media-latest-news/television-list/", "/news-releases/entertainment-media-latest-news/", "/news-releases/entertainment-media-latest-news/entertainment-media-latest-news-list/", "/news-releases/health-latest-news/", "/news-releases/health-latest-news/health-latest-news-list/", "/news-releases/health-latest-news/biometrics-list/", "/news-releases/health-latest-news/biotechnology-list/", "/news-releases/health-latest-news/clinical-trials-medical-discoveries-list/", "/news-releases/health-latest-news/dentistry-list/", "/news-releases/health-latest-news/fda-approval-list/", "/news-releases/health-latest-news/fitness-wellness-list/", "/news-releases/health-latest-news/health-care-hospitals-list/", "/news-releases/health-latest-news/health-insurance-list/", "/news-releases/health-latest-news/infection-control-list/", "/news-releases/health-latest-news/international-medical-approval-list/", "/news-releases/health-latest-news/medical-equipment-list/", "/news-releases/health-latest-news/medical-pharmaceuticals-list/", "/news-releases/health-latest-news/mental-health-list/", "/news-releases/health-latest-news/pharmaceuticals-list/", "/news-releases/health-latest-news/supplementary-medicine-list/", "/news-releases/health-latest-news/", "/news-releases/health-latest-news/health-latest-news-list/", "/news-releases/sports-latest-news/", "/news-releases/sports-latest-news/sports-latest-news-list/", "/news-releases/sports-latest-news/general-sports-list/", "/news-releases/sports-latest-news/outdoors-camping-hiking-list/", "/news-releases/sports-latest-news/sporting-events-list/", "/news-releases/sports-latest-news/sports-equipment-accessories-list/", "/news-releases/sports-latest-news/", "/news-releases/sports-latest-news/sports-latest-news-list/", "/news-releases/travel-latest-news/", "/news-releases/travel-latest-news/travel-latest-news-list/", "/news-releases/travel-latest-news/amusement-parks-and-tourist-attractions-list/", "/news-releases/travel-latest-news/gambling-casinos-list/", "/news-releases/travel-latest-news/hotels-and-resorts-list/", "/news-releases/travel-latest-news/leisure-tourism-list/", "/news-releases/travel-latest-news/outdoors-camping-hiking-list/", "/news-releases/travel-latest-news/passenger-aviation-list/", "/news-releases/travel-latest-news/travel-industry-list/", "/news-releases/travel-latest-news/", "/news-releases/travel-latest-news/travel-latest-news-list/", "#", "/news-releases/policy-public-interest-latest-news/", "/news-releases/policy-public-interest-latest-news/policy-public-interest-latest-news-list/", "/news-releases/policy-public-interest-latest-news/advocacy-group-opinion-list/", "/news-releases/policy-public-interest-latest-news/animal-welfare-list/", "/news-releases/policy-public-interest-latest-news/congressional-presidential-campaigns-list/", "/news-releases/policy-public-interest-latest-news/corporate-social-responsibility-list/", "/news-releases/policy-public-interest-latest-news/domestic-policy-list/", "/news-releases/policy-public-interest-latest-news/economic-news-trends-analysis-list/", "/news-releases/policy-public-interest-latest-news/education-list/", "/news-releases/policy-public-interest-latest-news/environmental-list/", "/news-releases/policy-public-interest-latest-news/european-government-list/", "/news-releases/policy-public-interest-latest-news/fda-approval-list/", "/news-releases/policy-public-interest-latest-news/federal-and-state-legislation-list/", "/news-releases/policy-public-interest-latest-news/federal-executive-branch-agency-news-list/", "/news-releases/policy-public-interest-latest-news/foreign-policy-international-affairs-list/", "/news-releases/policy-public-interest-latest-news/homeland-security-list/", "/news-releases/policy-public-interest-latest-news/labor-union-news-list/", "/news-releases/policy-public-interest-latest-news/legal-issues-list/", "/news-releases/policy-public-interest-latest-news/natural-disasters-list/", "/news-releases/policy-public-interest-latest-news/not-for-profit-list/", "/news-releases/policy-public-interest-latest-news/patent-law-list/", "/news-releases/policy-public-interest-latest-news/public-safety-list/", "/news-releases/policy-public-interest-latest-news/trade-policy-list/", "/news-releases/policy-public-interest-latest-news/us-state-policy-news-list/", "/news-releases/policy-public-interest-latest-news/", "/news-releases/policy-public-interest-latest-news/policy-public-interest-latest-news-list/", "#", "/news-releases/multicultural-latest-news/", "/news-releases/multicultural-latest-news/multicultural-latest-news-list/", "/news-releases/multicultural-latest-news/native-american-list/", "/news-releases/multicultural-latest-news/african-american-related-news-list/", "/news-releases/multicultural-latest-news/asian-related-news-list/", "/news-releases/multicultural-latest-news/children-related-news-list/", "/news-releases/multicultural-latest-news/diversity-equity-inclusion/", "/news-releases/multicultural-latest-news/hispanic-oriented-news-list/", "/news-releases/multicultural-latest-news/lesbian-gay-bisexual-list/", "/news-releases/multicultural-latest-news/mens-interest-list/", "/news-releases/multicultural-latest-news/people-with-disabilities-list/", "/news-releases/multicultural-latest-news/religion-list/", "/news-releases/multicultural-latest-news/senior-citizens-list/", "/news-releases/multicultural-latest-news/veterans-list/", "/news-releases/multicultural-latest-news/women-related-news-list/", "/news-releases/multicultural-latest-news/", "/news-releases/multicultural-latest-news/multicultural-latest-news-list/", "/ae/ar/news-releases/", "/comunicados-de-prensa/", "/comunicados-para-a-imprensa/", "/cs/tiskova-zprava/", "/da/pressemeddelelser/", "/de/pressemitteilungen/", "/es/comunicados-de-prensa/", "/fr/communiques-de-presse/", "/it/comunicati-stampa/", "/nl/persberichten/", "/no/pressemeldinger/", "/pl/komunikat-prasowy/", "/pt/comunicados-de-imprensa/", "/ru/press-releases/", "/sk/tlacova-sprava/", "/fi/lehdistotiedotteet/", "/sv/pressmeddelanden/", "/products/overview/", "/products/content-distribution/", "/products/communications-cloud/", "/products/ir-compliance/", "/guaranteed-paid-placement/", "/products/all-products/", "/contact-us/general-inquiries/", "/request-a-demo/", "/contact-us/editorial-bureaus/", "/contact-us/partnerships/", "/contact-us/media-inquiries/", "/contact-us/worldwide-offices/", "#nav-mobile", "/", "https://portal.prnewswire.com", "/contact-us/", "javascript:void(0)", "/contact-us/", "/contact-us/", "tel:+1-888-776-0942", "javascript:void(0)", "#", "https://portal.prnewswire.com/", "https://www.prnewswire.com/account/online-membership-form/", "https://portal.prnewswire.com/", "/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "/rss/", "https://gdpr.cision.com", "https://twitter.com/PRNewswire", "https://www.facebook.com/pages/PR-Newswire/26247320522", "https://www.linkedin.com/company/pr-newswire/", "/news-releases/", "/news-releases/multimedia/", "/news-releases/latest-news-topics/", "/news-releases/automotive-transportation-latest-news/", "/news-releases/business-technology-latest-news/", "/news-releases/entertainment-media-latest-news/", "/news-releases/financial-services-latest-news/", "/news-releases/general-business-latest-news/", "/news-releases/consumer-technology-latest-news/", "/news-releases/energy-latest-news/", "/news-releases/environment-latest-news/", "/news-releases/heavy-industry-manufacturing-latest-news/", "/news-releases/telecommunications-latest-news/", "/news-releases/consumer-products-retail-latest-news/", "/news-releases/entertainment-media-latest-news/", "/news-releases/health-latest-news/", "/news-releases/sports-latest-news/", "/news-releases/travel-latest-news/", "/news-releases/multicultural-latest-news/", "https://portal.prnewswire.com/", "https://www.prnewswire.com/account/online-membership-form/", "https://portal.prnewswire.com/", "/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "/rss/", "https://gdpr.cision.com", "https://twitter.com/PRNewswire", "https://www.facebook.com/pages/PR-Newswire/26247320522", "https://www.linkedin.com/company/pr-newswire/", "/products/overview/", "/products/content-distribution/", "/products/communications-cloud/", "/products/ir-compliance/", "/products/all-products/", "https://portal.prnewswire.com/", "https://www.prnewswire.com/account/online-membership-form/", "https://portal.prnewswire.com/", "/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "/rss/", "https://gdpr.cision.com", "https://twitter.com/PRNewswire", "https://www.facebook.com/pages/PR-Newswire/26247320522", "https://www.linkedin.com/company/pr-newswire/", "/contact-us/#general", "/request-a-demo/", "/contact-us/#editorial", "/contact-us/#partnerships", "/contact-us/#media", "/contact-us/#worldwide", "https://portal.prnewswire.com/", "https://www.prnewswire.com/account/online-membership-form/", "https://portal.prnewswire.com/", "/resources/", "https://www.cision.com/us/blog/", "https://prnmedia.prnewswire.com/", "/rss/", "https://gdpr.cision.com", "https://twitter.com/PRNewswire", "https://www.facebook.com/pages/PR-Newswire/26247320522", "https://www.linkedin.com/company/pr-newswire/", "/news-releases/johnson--johnson-initiates-pivotal-global-phase-3-clinical-trial-of-janssens-covid-19-vaccine-candidate-301136522.html", "/in/news-releases/johnson-amp-johnson-initiates-pivotal-global-phase-3-clinical-trial-of-janssen-s-covid-19-vaccine-candidate-877450595.html", "#", "/news/johnson-%26-johnson/", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", null, "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "javascript:void(0)", "#financial-modal", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=4217873583&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1522581176%26u%3Dhttps%253A%252F%252Fwww.jnj.com%252Fcoronavirus%252Fcovid-19-phase-3-study-clinical-protocol%26a%3Dstudy%2Bprotocol&a=protocolo+del+estudio", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=2587155939&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1181941441%26u%3Dhttps%253A%252F%252Fwww.janssen.com%252Finfectious-diseases-and-vaccines%252Fpatented-technologies%26a%3DAdVac%25C2%25AE%2Btechnology&a=tecnolog%C3%ADa+AdVac%C2%AE", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=1577797497&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D125471153%26u%3Dhttps%253A%252F%252Fwww.jnj.com%252Four-company%252Fjohnson-johnson-announces-collaboration-in-principle-with-the-united-kingdom-on-additional-phase-3-study-and-agreement-to-supply-its-covid-19-vaccine-candidate%26a%3Dcollaborate&a=colaborar", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=2174915427&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D972281942%26u%3Dhttp%253A%252F%252Fwww.jnj.com%252Fcoronavirus%26a%3Dwww.jnj.com%252Fcoronavirus&a=www.jnj.com%2Fcoronavirus", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=3848262118&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1797651163%26u%3Dhttp%253A%252F%252Fwww.jnj.com%252F%26a%3Dwww.jnj.com&a=www.jnj.com", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=4155470862&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D3430601698%26u%3Dhttp%253A%252F%252Fwww.twitter.com%252Fjnjnews%26a%3D%2540JNJNews&a=%40JNJNews", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=3845457817&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D3956113430%26u%3Dhttp%253A%252F%252Fwww.janssen.com%252F%26a%3Dwww.janssen.com&a=www.janssen.com", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=930301523&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D1289483207%26u%3Dhttps%253A%252F%252Ftwitter.com%252FJanssenGlobal%26a%3D%2540JanssenGlobal&a=%40JanssenGlobal", "http://www.sec.gov", "http://www.jnj.com", "https://c212.net/c/link/?t=0&l=es&o=2925902-1&h=175754704&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2925902-1%26h%3D650214627%26u%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F403394%252FJohnson_and_Johnson_Logo.jpg%26a%3Dhttps%253A%252F%252Fmma.prnewswire.com%252Fmedia%252F403394%252FJohnson_and_Johnson_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F403394%2FJohnson_and_Johnson_Logo.jpg", "http://www.jnj.com", "https://gdpr.cision.com/PRN-Consumer-Newsletter", "https://gdpr.cision.com/PRN-Consumer-Newsletter", "https://gdpr.cision.com/PRN-Consumer-Newsletter", "https://gdpr.cision.com/PRN-Consumer-Newsletter", "tel:Cision%20Distribution%20888-776-0942", "javascript://Chat", "/contact-us/general-inquiries/", "/request-a-demo/", "/contact-us/editorial-bureaus/", "/contact-us/partnerships/", "/contact-us/media-inquiries/", "/contact-us/worldwide-offices/", "https://twitter.com/PRNewswire", "https://www.facebook.com/PR-Newswire-26247320522/", "https://www.linkedin.com/company/pr-newswire/", "/products/communications-cloud/", "/products/marketing/", "/products/public-relations/", "/products/ir-compliance/", "/products/agency/", "https://www.smallbusinesspr.com/request_information", "/products/all-products/", "https://prnewswire.mediaroom.com/index.php", "https://www.cision.com/us/?utm_medium=website&utm_source=prnewswire&utm_content=cishomepage&utm_campaign=prnewswire", "/contact-us/prnewswire-partners/", "/contact-us/become-a-partner/", "https://www.cision.com/careers/", "https://www.cision.com/about/accessibility/", "https://www.prnasia.com/", "https://prnewswire.com.br/", "https://www.newswire.ca/", "/cs/tiskova-zprava/", "/da/pressemeddelelser/", "/fi/lehdistotiedotteet/", "/fr/communiques-de-presse/", "/de/pressemitteilungen/", "/in/news-releases/", "/il/news-releases/", "/it/comunicati-stampa/", "https://prnewswire.com.mx/", "/ae/news-releases/", "https://www.prnewswire.com/ae/ar/news-releases/", "/nl/persberichten/", "/no/pressemeldinger/", "/pl/komunikat-prasowy/", "/pt/comunicados-de-imprensa/", "/ru/press-releases/", "/sk/tlacova-sprava/", "/es/comunicados-de-prensa/", "/sv/pressmeddelanden/", "https://www.prnewswire.co.uk/", "/news-releases/", "https://portal.prnewswire.com/Login.aspx", "https://profnet.prnewswire.com/ProfNetHome/What-is-Profnet.aspx", "/contact-us", "/products/overview", "https://prnewswire.mediaroom.com/index.php", "", "/news-releases/", "https://portal.prnewswire.com/Login.aspx", "https://profnet.prnewswire.com/ProfNetHome/What-is-Profnet.aspx", "tel:Cision%20Distribution%20Helpline", "/terms-of-use/", "/privacy-policy/", "/prn-information-security-policy/", "/sitemap/", "/rss/", "/cookie-settings/", "https://www.cision.com/us/?utm_medium=website&utm_source=prnewswire&utm_content=cishomepage&utm_campaign=prnewswire", "javascript://Chat"]}